Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
the words "FDA recall" on a board

Boston Scientific recalls premixed embolic agent after two deaths

There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.  

healthcare value value-based care money dollar

Johnson & Johnson to acquire Shockwave Medical for $13.1B

The rumors, it seems, were true. Once the deal is finalized, Shockwave Medical will operate as a business unit within Johnson & Johnson MedTech.

the words "FDA recall" on a board

FDA announces recall of more than 300,000 catheter kits after 10 injuries, 1 death

This recall is due to reports of “increased resistance” when using the devices. There have been 194 customer complaints about the issue so far. 

Video - Ken Rosenfield, MD, MGH, and William Gray, MD, Lankenau Heart, explain impact of new CMS coverage for carotid stenting.

How a big CMS update on carotid stenting could impact interventional cardiology

Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift. 

Thumbnail

Implementing a same-day PCI discharge pathway boils down to correct patient selection

Safety is key to which individuals are selected for SDD, and there can be benefits to both patients and health systems as this becomes the predominant model of care in elective PCI.

Best in KLAS 2024: New rankings for cardiovascular information systems, hemodynamic solutions

Hospital end users ranked the CVIS and hemodynamic systems they use, shedding light on their working relationships with IT vendors. 

Thumbnail

Cardiologists lead push for Aetna to reconsider ‘restrictive,’ ‘inconsistent’ reimbursement proposals

The policies cover a wide range of interventional therapies, including Shockwave Medical's IVL technology and intravascular ultrasound. 

Johnson & Johnson acquires medical device company behind new LAA technology for $400M

The deal could also include additional clinical and regulatory milestone payments in the years ahead.

Displaying 25 - 32 of 79

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”